Osteoporosis News

In patients with knee osteoarthritis, there was a high concordance between scanning electron microscopy and compensated polarized light microscopy in detecting calcium pyrophosphate crystals in synovial fluid, according to study findings. However, there was a low concordance between scanning electron microscopy and alizarin red staining in detecting basic calcium phosphate crystals.

The PANLAR consensus has updated its recommendations for osteoarthritis management of the hand, hip and knee.

Cam deformity and acetabular dysplasia were associated hip osteoarthritis, according to a recently published study.

Knee pain severity — not structural damage — increased the risk for widespread pain in patients at risk for osteoarthritis, according to study findings.

Among the uninsured, severe knee pain was associated with less willingness to undergo a total knee replacement, according to recently published findings.

The board of directors of the American Academy of Orthopaedic Surgeons has approved a revised position statement that notes physicians should screen, monitor and help get treatment for elderly patients and other patients at risk for osteoporosis after a bone fracture in order to prevent subsequent fractures.

The FDA recently accepted the Biologics License Application for review of romosozumab, according to a press release from Amgen and UCB.

ATLANTA — In this video exclusive, E. Michael Lewiecki, MD, FACP, FACE, director of New Mexico Clinical Research and Osteoporosis Center in Albuquerque, discusses the new osteoporosis drug abaloparatide, a synthetic form of human parathyroid hormone-related protein, designed to stimulate bone formation without also stimulating as much bone resorption as other agents.

In postmenopausal women with osteoporosis, the monoclonal antibody romosozumab was associated with a lower risk for new vertebral fractures vs. placebo at both 12 and 24 months, according to study data presented at the American Society for Bone and Mineral Research annual meeting and simultaneously published online in The New England Journal of Medicine.

ATLANTA — In this video exclusive, E. Michael Lewiecki, MD, FACP, FACE, director of New Mexico Clinical Research and Osteoporosis Center in Albuquerque, discusses his study on the rate of hip fractures in the United States and the reduction in reimbursement for DXA testing.